We Connect People.

About Us

Propel Research

What we do

PROPEL brings together cross-disciplinary scientists, industry and decision maker stakeholders to answer real-world questions of importance to healthcare teams, patients and caregivers.

Bringing peoplentogether to endnpoverty for good

Our Mission

Ullamco laboris nisi ut aliquip ex ea commodo con-sequat. Duis aute irure dolor in reprehenderit in vo-luptate velit esse cillum dolore eu fugiat nulla paria-tur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium.

Our Vision

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiamillo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia .

Why us.

Our Values

Translatability.

Translational ideas that reach the bedside

Openness.

Open to new ways of thinking and methods

Inclusive.

Inclusive and balanced teams

Aspirational.

Aspirational ideas and output

Excellence.

Excellence in academic medicine and patient care

Who We Are.

Awesome Team

Cardiac Anesthesiologist
Angela Jerath is a cardiac anesthesiologist and trained cardiovascular intensivist who has lived and trained across many world continents.
She founded PROPEL in 2018 with the aim of using clinical epidemiology and translational methodologies to improve care for patients needing complex surgery and life-saving critical care.
She focuses on innovative drug repurposing, healthcare devices, new technology and data driven studies. She clinically practices at Sunnybrook Health Sciences Centre and is a scientist at Sunnybrook Research Institute, Toronto, Canada.
Urologic Oncologist
Christopher Wallis is a fellowship-trained urologic oncologist, epidemiologist, and health services researcher. He has expertise in a wide variety of research methodologies and statistical approaches that he leverages to understand and improve care for patients with cancer and those needing surgery. He works extensively with multi-institutional and multi-national collaborative groups and has consulted widely on issues of study design and patient care.

Support us.

Support our initiative